ES2109276T3 - Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas. - Google Patents

Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas.

Info

Publication number
ES2109276T3
ES2109276T3 ES91917948T ES91917948T ES2109276T3 ES 2109276 T3 ES2109276 T3 ES 2109276T3 ES 91917948 T ES91917948 T ES 91917948T ES 91917948 T ES91917948 T ES 91917948T ES 2109276 T3 ES2109276 T3 ES 2109276T3
Authority
ES
Spain
Prior art keywords
prevent
pharmaceutical composition
ischemic diseases
treat ischemic
tropolone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91917948T
Other languages
English (en)
Inventor
Noriie Itoh
Mineo Kunihara
Hiroshi Kushida
Whorter William W Mc
Syunji Nomura
Kazunori Ozawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2229536A external-priority patent/JPH04120069A/ja
Priority claimed from JP5625291A external-priority patent/JPH04247077A/ja
Priority claimed from JP3039173A external-priority patent/JPH04295471A/ja
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2109276T3 publication Critical patent/ES2109276T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

LA INVENCION SUMINISTRA NUEVOS DERIVADOS DE LA TROPOLONA DE LA FORMULA (I) EN DONDE R1 ES UN GRUPO DE PIPERACINIL O DE BENZOTIAZOLIDINIL SUBSTITUIDO O INSUBSTITUIDO, ASIMISMO SE PRESENTAN LAS COMPOSICIONES FARMACEUTICAS DE LOS MISMOS. ESTOS COMPUESTOS SON UTILES PARA LA PREVENCION Y EL TRATAMIENTO DE ENFERMEDADES ISQUEMICAS, INCLUYENDO ENFERMEDADES CEREBROVASCULARES Y CARDIOVASCULARES.
ES91917948T 1990-08-29 1991-08-27 Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas. Expired - Lifetime ES2109276T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2229536A JPH04120069A (ja) 1990-08-29 1990-08-29 トロポロン誘導体およびこれを有効成分とする虚血性疾患の予防・治療剤
JP5625291A JPH04247077A (ja) 1991-01-31 1991-01-31 トロポロン誘導体およびそれを有効成分とする虚血性疾患の予防・治療剤
JP3039173A JPH04295471A (ja) 1991-02-08 1991-02-08 トロポロン誘導体およびこれを有効成分とする虚血性疾患の予防・治療剤

Publications (1)

Publication Number Publication Date
ES2109276T3 true ES2109276T3 (es) 1998-01-16

Family

ID=27290061

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91917948T Expired - Lifetime ES2109276T3 (es) 1990-08-29 1991-08-27 Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas.

Country Status (14)

Country Link
US (1) US5594144A (es)
EP (1) EP0546102B1 (es)
JP (1) JP2512656B2 (es)
KR (1) KR100232324B1 (es)
AT (1) ATE159251T1 (es)
AU (1) AU651629B2 (es)
CA (1) CA2087004C (es)
DE (1) DE69127976T2 (es)
DK (1) DK0546102T3 (es)
ES (1) ES2109276T3 (es)
FI (1) FI930860L (es)
HU (2) HUT65943A (es)
NO (1) NO305801B1 (es)
WO (1) WO1992004338A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703071A (en) * 1990-08-29 1997-12-30 Pharmacia & Upjohn Company Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases
CN1063443C (zh) * 1995-03-28 2001-03-21 日本脏器制药株式会社 新的苯并噻唑衍生物
CN1227550A (zh) * 1996-08-22 1999-09-01 赫彻斯特马里恩鲁斯公司 作为选择性多巴胺d4受体配体的环庚三烯酮基哌嗪类
US5998414A (en) * 1996-08-22 1999-12-07 Hoechst Marion Roussel, Inc. Troponyl piperazines as dopamine D4 receptor ligands
KR100508626B1 (ko) * 1997-06-27 2005-08-17 니폰 가야꾸 가부시끼가이샤 빈뇨·요실금 치료·예방제 및 트로폰 유도체
EP1144387A1 (en) 1998-12-04 2001-10-17 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
NZ539828A (en) 2001-05-18 2007-01-26 Astrazeneca Ab 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
US6689342B1 (en) * 2002-07-29 2004-02-10 Warner-Lambert Company Oral care compositions comprising tropolone compounds and essential oils and methods of using the same
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
KR101234421B1 (ko) 2004-08-02 2013-02-18 아스트라제네카 아베 디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
KR101036322B1 (ko) 2009-11-12 2011-05-23 한국과학기술연구원 히노키티올의 프롤릴 하이드록실라제 2 활성 저해 용도
FR2993462B1 (fr) * 2012-07-18 2014-10-17 Ct Eugene Marquis Composition a usage therapeutique comprenant une phrase organique lipidique et un complexe de terre rare radioisotopique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1153764A (en) * 1980-02-25 1983-09-13 Jehan F. Bagli 2-(1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
DK0546102T3 (da) 1998-06-02
AU8720391A (en) 1992-03-30
WO1992004338A1 (en) 1992-03-19
AU651629B2 (en) 1994-07-28
CA2087004A1 (en) 1992-03-01
HUT65943A (en) 1994-08-29
NO930669D0 (no) 1993-02-25
JP2512656B2 (ja) 1996-07-03
FI930860A7 (fi) 1993-02-25
US5594144A (en) 1997-01-14
DE69127976T2 (de) 1998-03-05
EP0546102A1 (en) 1993-06-16
FI930860A0 (fi) 1993-02-25
NO930669L (no) 1993-02-25
DE69127976D1 (de) 1997-11-20
NO305801B1 (no) 1999-07-26
HU211307A9 (en) 1995-11-28
FI930860L (fi) 1993-02-25
ATE159251T1 (de) 1997-11-15
JPH06509318A (ja) 1994-10-20
CA2087004C (en) 1998-04-21
EP0546102B1 (en) 1997-10-15
KR100232324B1 (ko) 1999-12-01
HU9300533D0 (en) 1993-05-28

Similar Documents

Publication Publication Date Title
SE9002206D0 (sv) New compounds
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
ES2038172T3 (es) Procedimiento para preparar carboxamidas heterociclicas.
ATE243209T1 (de) Tetrahydro gamma-carboline
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
BG103426A (en) Derivatives of substituted 4-biphenyl-4-hydroxy-oil acids as inhibitors of matrix metalloproteases
DK0546102T3 (da) Tropolonderivater og farmaceutisk sammensætning deraf til hindring og behandling af iskæmiske sygdomme
BR8104800A (pt) Derivativos de arilamina ,processo para sua preparacao e composicoes ,processo para a preparacao de composicoes ,empprego e processo para o combate e/ou impedimento de uma infestacao de plantas por fungos
ES2143459T3 (es) 4,5-dihidro-1h-pirazol-1-carboxamidas n-aril-3-aril-4 sustituidas y procedimientos para su produccion.
MX9306394A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
AR035003A1 (es) Derivados de propanolamina relacionados con acidos biliares, procedimiento para su preparacion, medicamentos conteniendo estos compuestos y su empleo para la preparacion de medicamentos
DE69112070D1 (de) Anthelmintische und coccidizide 3-carbamoyl-4-hydroxycumarine, ihre verwendung und zusammensetzungen.
PA8429501A1 (es) Derivados de acido 3-aributirico sustituido como inhibidores de la metaloproteasa de matriz
ES2052622T3 (es) Derivados de benzodioxol, compuestos que los comprenden y utilizacion de los mismos para la fabricacion de medicamentos.
MX9300008A (es) Nucleosidos terapeuticos.
ATE9992T1 (de) 3-(buta-1',3'-dienyl)-substituierte derivate der cyclopropan-1-carbonsaeure, zusammensetzungen zur bekaempfung von pflanzenund warmblueterschaedlingen, sowie die parfuemierenden zusammensetzungen, die sie enthalten; ihre herstellung.
ES2168189B1 (es) Derivados de piperazinona
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
ES2191170T3 (es) Nuevos (-)-enantiomeros de derivados de cis-3,4-cromano utiles en la prevencion y tratamiento de sindromes o enfermedades relacionadas con el estrogeno.
ES2093040T3 (es) Hidroximetil-indolizidinas y quinolizidinas.
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.
DE69222143D1 (de) Indanderivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 546102

Country of ref document: ES